NEW YORK (GenomeWeb News) – Molecular diagnostic technology firm Quanterix said today that it will work with Germany's Stratec Biomedical in a partnership to develop, manufacture, and market an automated testing tool aimed at the life sciences and medical in vitro diagnostic markets.
The companies will customize Stratec's technology to develop an automated version of Quanterix's Single Molecule Array (SiMoA) technology.